AP

Athrayil Puthankayil Radhakrishnan

Active Director Director DIN 00099364
DIN 00099364 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Athrayil Puthankayil Radhakrishnan

Data last updated:

Athrayil Puthankayil Radhakrishnan is a Director at Diabetes Research Foundation Of India (since 2026).

DIN 00099364
Primary Designation Director
First Appointment 17 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Aug 20262026Active

Directorship timeline

Open interactive timeline →
Diabetes Research Foundation Of India
Premium access

Shareholding and investment profile for Athrayil Puthankayil Radhakrishnan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Athrayil Puthankayil Radhakrishnan

Athrayil Puthankayil Radhakrishnan currently holds 1 directorship: Diabetes Research Foundation Of India (Director, since 17 Aug 2026).

Athrayil Puthankayil Radhakrishnan was first appointed on 17 Aug 2026 as Director at Diabetes Research Foundation Of India.

The current boards of Athrayil Puthankayil Radhakrishnan's companies include Geetha Radhakrishnan (Diabetes Research Foundation Of India), Jubariya Mannengal Eledath (Diabetes Research Foundation Of India), Priya Suresh (Diabetes Research Foundation Of India), Shaji Abdul Gafoor Khan (Diabetes Research Foundation Of India), Suresh Kumar (Diabetes Research Foundation Of India).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available